Lawmakers Probe FDA Over Handling Of Cordis Warning Letter
This article was originally published in The Gray Sheet
Executive Summary
The House Energy and Commerce Committee sent letters to FDA and Johnson & Johnson Aug. 13 requesting documents as part of an inquiry into FDA's Office of Regulatory Affairs